Allstate Corporation’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.2M | Buy |
117,857
+21,762
| +23% | +$4.87M | 0.27% | 49 |
|
|
2025
Q4 | $16.4M | Buy |
96,095
+49,743
| +107% | +$7.74M | 0.22% | 58 |
|
|
2025
Q3 | $6.21M | Buy |
46,352
+43,737
| +1,673% | +$4.63M | 0.14% | 75 |
|
|
2025
Q2 | $255K | Sell |
2,615
-45,693
| -95% | -$3.62M | 0.02% | 151 |
|
|
2025
Q1 | $3.51M | Buy |
+48,308
| New | +$3.8M | 0.1% | 124 |
|
|
2024
Q3 | – | Sell |
-4,710
| Closed | -$502K | – | 179 |
|
|
2024
Q2 | $502K | Hold |
4,710
| – | – | 0.04% | 116 |
|
|
2024
Q1 | $458K | Sell |
4,710
-60
| -1% | -$5.28K | 0.03% | 121 |
|
|
2023
Q4 | $374K | Sell |
4,770
-490
| -9% | -$33.4K | 0.03% | 135 |
|
|
2023
Q3 | $330K | Hold |
5,260
| – | – | 0.02% | 145 |
|
|
2023
Q2 | $338K | Buy |
5,260
+30
| +0.6% | +$1.69K | 0.02% | 150 |
|
|
2023
Q1 | $277K | Sell |
5,230
-47,810
| -90% | -$2.35M | 0.02% | 157 |
|
|
2022
Q4 | $2.23M | Buy |
53,040
+13,960
| +36% | +$584K | 0.07% | 182 |
|
|
2022
Q3 | $1.43M | Sell |
39,080
-13,780
| -26% | -$613K | 0.04% | 253 |
|
|
2022
Q2 | $2.25M | Sell |
52,860
-11,910
| -18% | -$567K | 0.07% | 169 |
|
|
2022
Q1 | $3.48M | Sell |
64,770
-40,610
| -39% | -$2.36M | 0.09% | 153 |
|
|
2021
Q4 | $7.58M | Buy |
105,380
+84,390
| +402% | +$5.29M | 0.14% | 107 |
|
|
2021
Q3 | $1.2M | Sell |
20,990
-3,050
| -13% | -$186K | 0.05% | 252 |
|
|
2021
Q2 | $1.56M | Sell |
24,040
-1,460
| -6% | -$92.2K | 0.05% | 193 |
|
|
2021
Q1 | $1.52M | Sell |
25,500
-6,370
| -20% | -$347K | 0.05% | 216 |
|
|
2020
Q4 | $1.5M | Buy |
31,870
+800
| +3% | +$33.7K | 0.05% | 195 |
|
|
2020
Q3 | $1.03M | Sell |
31,070
-4,190
| -12% | -$144K | 0.03% | 230 |
|
|
2020
Q2 | $1.14M | Buy |
35,260
+3,970
| +13% | +$108K | 0.04% | 219 |
|
|
2020
Q1 | $751K | Sell |
31,290
-76,710
| -71% | -$2.21M | 0.03% | 269 |
|
|
2019
Q4 | $3.16M | Sell |
108,000
-100
| -0.1% | -$2.66K | 0.06% | 206 |
|
|
2019
Q3 | $2.5M | Buy |
108,100
+59,350
| +122% | +$1.25M | 0.04% | 243 |
|
|
2019
Q2 | $916K | Hold |
48,750
| – | – | 0.02% | 397 |
|
|
2019
Q1 | $873K | Buy |
48,750
+28,890
| +145% | +$482K | 0.02% | 305 |
|
|
2018
Q4 | $270K | Buy |
+19,860
| New | +$285K | 0.01% | 365 |
|
|
2017
Q3 | – | Sell |
-69,810
| Closed | -$987K | – | 160 |
|
|
2017
Q2 | $987K | Buy |
+69,810
| New | +$1.02M | 0.05% | 192 |
|
|
2016
Q3 | – | Sell |
-42,780
| Closed | -$360K | – | 191 |
|
|
2016
Q2 | $360K | Buy |
+42,780
| New | +$344K | 0.02% | 148 |
|
Other funds holding LRCX
VCM
VPM
Allstate Corporation's LRCX Position: Q1 2026 in Review
Allstate Corporation increased its Lam Research (LRCX) stake by 23% in Q1 2026, buying an estimated $4.87M and bringing the position to 117,857 shares worth $25.2M. The position accounts for 0.27% of the portfolio, ranked #49.
Allstate Corporation first reported a position in LRCX in Q2 2016 and has held it in 30 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.
- Allstate Corporation held 117,857 shares of Lam Research worth $25.2M as of Q1 2026.
- Allstate Corporation bought 21,762 Lam Research shares in Q1 2026, an estimated $4.87M.
- Lam Research made up 0.27% of Allstate Corporation's portfolio in Q1 2026, its #49 holding.
- Allstate Corporation first reported a position in Lam Research in Q2 2016 and has held it in 30 quarters since.
- 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.